DIAGNOSTIC AND PROGNOSTIC METHODS FOR LUNG DISORDERS USING GENE EXPRESSION PROFILES FROM NOSE EPITHELIAL CELLS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

14690182

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods for diagnosis and prognosis of lung cancer using expression analysis of one or more groups of genes, and a combination of expression analysis from a nasal epithelial cell sample. The methods of the invention provide far less invasive method with a superior detection accuracy for lung cancer when compared to any other currently available method for lung cancer diagnostic or prognosis. The invention also provides methods of diagnosis and prognosis of other lung diseases, such as lung cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MADRYN HEALTH PARTNERS LPC/O MADRYN ASSET MANAGEMENT LP 140 E 45TH STREET 15TH FLOOR SUITE B NEW YORK NY 10017

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berman, Jeffrey S Cambridge, US 6 51
Brody, Jerome S Boston, US 23 188
O'Regan, Anthony W Galway, IE 6 51
Spira, Avrum Newton, US 33 222

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation